Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetes

Medical treatment of stable angina: A tailored therapeutic approach

(2016) Athanasios J. Manolis et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Management of stable angina: A commentary on the European Society of Cardiology guidelines

(2016) Giuseppe Ambrosio et al.   European Journal of Preventive Cardiology

Is Treatment with Trimetazidine Beneficial in Patients with Chronic Heart Failure?

(2014) Xiang Zhou et al.   PLoS One

2013 ESC guidelines on the management of stable coronary artery disease

(2013)   EUROPEAN HEART JOURNAL

Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: Results from an international multicentre retrospective cohort study

(2012) Gabriele Fragasso et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina — The VASCO-angina study

(2012) Cristiana Vitale et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Type 2 Diabetes Is Associated With Increased Pulse Wave Velocity Measured at Different Sites of the Arterial System but Not Augmentation Index in a Chinese Population

(2011) Minghua Zhang et al.   CLINICAL CARDIOLOGY

Trimetazidine improves exercise performance in patients with peripheral arterial disease

(2011) Cristiana Vitale et al.   PHARMACOLOGICAL RESEARCH

Trimetazidine: a meta-analysis of randomised controlled trials in heart failure

(2010) D. Gao et al.   HEART

Effects of Metabolic Approach in Diabetic Patients with Coronary Artery Disease

(2009) Gabriele Fragasso et al.   CURRENT PHARMACEUTICAL DESIGN

Effects of Trimetazidine on Myocardial Perfusion and Left Ventricular Systolic Function in Type 2 Diabetic Patients With Ischemic Cardiomyopathy

(2009) Romualdo Belardinelli et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY